Highland Capital Management, LLC Alkermes Plc. Transaction History

Highland Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 16, 2019	SELL	$27.94 - $44.61 $142,494 - $227,511	-5,100 Closed	0 $0
Q1 2018 Apr 16, 2018	SELL	$53.61 - $67.26 $16,083 - $20,178	-300 Reduced 5.56%	5,100 $296,000
Q3 2017 Oct 10, 2017	BUY	$49.16 - $54.45 $265,464 - $294,030	5,400	5,400 $275,000

346

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.76B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.